Infectious diseases (ID) represent one of the major causes of death in the world.

The growth of ID incidence has lead to a continuous need for novel diagnostic tests to new agents and improvement of performance of the ones already on the market.

In addition, the increased number of diagnostic tests to be performed everyday in a routine lab has elicited the demand of tests that are easy to perform and quick in providing results for faster diagnosis and therapy.

Infectious disease serology means determination of antibodies to different pathogens with the following aims:
•    to assess the presence of ongoing infection or to follow progression of the disease
•    to assess the immune status.

Since 2001, DiaSorin has launched a broad array of new products for diagnosis of infectious diseases, including more than 30 assays* on the LIAISON® instrument.

All DiaSorin infectious disease products are registered in compliance with the European CE mark rules and most of them are also FDA-approved or FDA-cleared in the US.

*Outside the US and Canada only